Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Johndean,
I belive so although I haven't had any notification from my trading platform HL as yet.
Because I have been here for a few years now I will take up an offer at 1p, maybe not my full entitlement but I can not simply let the oppertunity pass me by.
Just going to have to wait some more ....
If held on record date. 20th yes.
Are existing holders able to buy the offer at 1p
Keep the deals rolling in over the next year or two. Into the top most institutions. Its fantastic now keep adding to the beating of forecasts. 2024 already beaten. Plenty to come
"Technology may be good (hard to know) but take up is no where near it needs to be for this to be a viable company that can will return rather than eat shareholders money."
Spot-on, Pyueck. This lot showed their true capabilities when the initial FDA submission fell short.
I see no point whatever in selling, and every incentive to take the 9/10 offer. With financing assured, the only way for the sp is up.
Be rude not to
Same here
Happy with that purchase and then I have my batch at 1p. This could end up being a lovely tonic
Puke don’t make me laugh, u were never invested here lol
Going down
DYOR
Not going to be participating. Not at all convinced this money won’t be eaten up on director and employee salaries. Technology may be good (hard to know) but take up is no where near it needs to be for this to be a viable company that can will return rather than eat shareholders money. Surely directors looked at a complete sale, fact that it didn’t happen speaks volumes. Don’t be surprised if this is first of a few fundraisers.
Record Date for the Open Offer 6:00 p.m. on 20 May 2024.
So if you held a qty of shares on this day that is what your open offer allocation will be. Effectively doubling holdings at 1p. Is not to be sniffed at.
Any bought or sold today or after doesn't change a thing? Right?
Bearing in mind the sp had been hammered on good news because of finance in the background so we weren't at fair value. So there's the dilution but then there's the positives.
DAMN
Okay thanks JJ in that case I might just try for 25 and see how that goes
Jusr a detail on record date, it records yesterdaya holding even if your shares change today. Ie buy or sell.
I think I'm correct?
I think I’ll try to buy 15 for every 10 I currently own JJ
Might even push for 20 or 25 if we see a lot of selling today because that will give us a clear sign that they won’t be taking any part in the offer
Yes we do. For every 10 held you can buy 9 and also take up extra if sufficient available.
The huge losers here are Directors, ex directors, retail and institutions excluding Nukem and Bracco that held prior to the placing
I’ve not had any msg about open offer participation. Trying to catch up here —- do we get to buy in?
Can request an excess to the 9 out of 10 slick. So more at 1p for shareholders. Gla
9 Open Offer Shares for every 10 Existing Ordinary Shares held on the Record Date, at a price of 1 pence per Open Offer share
Shareholders subscribing for their full entitlement under the Open Offer may also request additional Open Offer Shares through the Excess contained in the Launch Announcement and which is expected to be posted to Shareholders on 23 May 2024. The Circular will also be available on the Company's website: https://www.polarean-ir.com/content/investors/shareholder-information.
There's "fair market value" and then there's being diluted 4:1 - you literally own nearly 5x less of the company. 1p strike price is bad enough... Issuing 700m + shares is absolutely criminal.
Can Join in at 1p. When obviously the company with cash and future is worth a lot more than it was yesterday when the funds are banked. Our plan is actioned with it, the sales keep coming in and we hopefully keep smashing targets...
Even though share dilution causes you to own less of the company percentage-wise, it doesn't necessarily mean your stock is worth less. In fact, the fair market value (FMV) of a company's stock generally increases after a funding round, so the overall value of your shares may actually go up.
Read the previous rns and can't see over $5m being mentioned as you claim. In case I missed it can you quote from the rns.
What the company does confirm however in yesterday's RNs is $2-$3m:
The Commercial Plan, as announced in the 2024 Polarean Strategy Update in February, remains in effect and the Company reaffirm the near term guidance of achieving revenues of US$2 million to US$3 million in 2024. A number of highly active discussions with academic and medical institutions are positive and ongoing